| dc.contributor.author |
Stayoussef, Mouna |
|
| dc.contributor.author |
Benmansour, Jihen |
|
| dc.contributor.author |
Al-Jenaidi, Fayza A. |
|
| dc.contributor.author |
Nemr, Rita |
|
| dc.contributor.author |
Ali, Muhallab E. |
|
| dc.contributor.author |
Mahjoub, Touhami |
|
| dc.contributor.author |
Almawi, Wassim Y. |
|
| dc.date.accessioned |
2019-05-29T08:53:20Z |
|
| dc.date.available |
2019-05-29T08:53:20Z |
|
| dc.date.copyright |
2009 |
en_US |
| dc.date.issued |
2019-05-29 |
|
| dc.identifier.issn |
1556-679X |
en_US |
| dc.identifier.uri |
http://hdl.handle.net/10725/10693 |
|
| dc.description.abstract |
The contribution of HLA DRB-DQB to type 1 diabetes (T1D) in Bahrainis, Lebanese, and Tunisians was investigated. DRB1*030101-DQB1*0201 was a locus that conferred susceptibility in three populations, while DRB1*040101-DQB1*0302 was a locus that conferred susceptibility only in Tunisians and Bahrainis. The DRB1*100101-DQB1*050101 (Bahrainis) and DRB1*150101-DQB1*060101 (Lebanese) loci were largely protective. The contribution of HLA to T1D must be evaluated with regard to ethnic background. |
en_US |
| dc.language.iso |
en |
en_US |
| dc.title |
Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes |
en_US |
| dc.type |
Article |
en_US |
| dc.description.version |
Published |
en_US |
| dc.author.school |
SOM |
en_US |
| dc.author.idnumber |
201004815 |
en_US |
| dc.author.department |
N/A |
en_US |
| dc.description.embargo |
N/A |
en_US |
| dc.relation.journal |
Clinical and Vaccine Immunology |
en_US |
| dc.journal.volume |
16 |
en_US |
| dc.journal.issue |
1 |
en_US |
| dc.article.pages |
136-138 |
en_US |
| dc.identifier.doi |
http://dx.doi.org/10.1128/CVI.00215-08 |
en_US |
| dc.identifier.ctation |
Stayoussef, M., Benmansour, J., Al-Jenaidi, F. A., Nemr, R., Ali, M. E., Mahjoub, T., & Almawi, W. Y. (2009). Influence of common and specific HLA-DRB1/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes. Clin. Vaccine Immunol., 16(1), 136-138. |
en_US |
| dc.author.email |
rita.nemr@lau.edu.lb |
en_US |
| dc.identifier.tou |
http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php |
en_US |
| dc.identifier.url |
https://cvi.asm.org/content/16/1/136.short |
en_US |
| dc.author.affiliation |
Lebanese American University |
en_US |